Smiles2Dock: an open large-scale multi-task dataset for ML-based molecular docking
Docking is a crucial component in drug discovery aimed at predicting the binding conformation and affinity between small molecules and target proteins. ML-based docking has recently emerged as a prominent approach, outpacing traditional methods like DOCK and AutoDock Vina in handling the growing scale and complexity of molecular libraries. However, the availability of comprehensive and user-friendly datasets for training and benchmarking ML-based docking algorithms remains limited. We introduce Smiles2Dock, an open large-scale multi-task dataset for molecular docking. We created a framework combining P2Rank and AutoDock Vina to dock 1.7 million ligands from the ChEMBL database against 15 AlphaFold proteins, giving us more than 25 million protein-ligand binding scores. The dataset leverages a wide range of high-accuracy AlphaFold protein models, encompasses a diverse set of biologically relevant compounds and enables researchers to benchmark all major approaches for ML-based docking such as Graph, Transformer and CNN-based methods. We also introduce a novel Transformer-based architecture for docking scores prediction and set it as an initial benchmark for our dataset. Our dataset and code are publicly available to support the development of novel ML-based methods for molecular docking to advance scientific research in this field.
Code (1)
Tasks
BenchmarkingDrug DiscoveryMolecular DockingMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
A deep-learning view of chemical space designed to facilitate drug discovery
Drug discovery projects entail cycles of design, synthesis, and testing that yield a series of chemically related small molecules whose properties, such as binding affinity to a given target protein, are progressively ta…
Design SynthesisDrug DiscoveryPrediction of Binding Affinity for ErbB Inhibitors Using Deep Neural Network Model with Morgan Fingerprints as Features
The ErbB receptor family, including EGFR and HER2, plays a crucial role in cell growth and survival and is associated with the progression of various cancers such as breast and lung cancer. In this study, we developed a …
Drug DiscoveryCogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models
The novel nature of SARS-CoV-2 calls for the development of efficient de novo drug design approaches. In this study, we propose an end-to-end framework, named CogMol (Controlled Generation of Molecules), for designing ne…
AttributeDrug DesignRetrosynthesisSpecificityDockSmith: Scaling Reliable Coding Environments via an Agentic Docker Builder
Reliable Docker-based environment construction is a dominant bottleneck for scaling execution-grounded training and evaluation of software engineering agents. We introduce DockSmith, a specialized agentic Docker builder …
MolLingo: Molecule-Native Representations for LLM-Powered Scientific Agents
We present MolLingo, a multi-agent system that emulates the reasoning process of a chemist to automate molecular design. Existing LLM-based approaches either operate as standalone generative models without access to exte…